Tumour-selective drug activation: a GDEPT approach utilizing cytochrome P450 1A1 and AQ4N

Anita Yakkundi, V. McErlane, Margaret Murray, Helen McCarthy, C. Ward, C.M. Hughes, L.H. Patterson, David Hirst, S.R. McKeown, Tracy Robson

Research output: Contribution to journalArticle

36 Citations (Scopus)
Original languageEnglish
Pages (from-to)598-605
Number of pages8
JournalCancer Gene Therapy
Volume13(6)
Issue number6
DOIs
Publication statusPublished - Jan 2006

ASJC Scopus subject areas

  • Cancer Research
  • Genetics

Cite this

Yakkundi, A., McErlane, V., Murray, M., McCarthy, H., Ward, C., Hughes, C. M., Patterson, L. H., Hirst, D., McKeown, S. R., & Robson, T. (2006). Tumour-selective drug activation: a GDEPT approach utilizing cytochrome P450 1A1 and AQ4N. Cancer Gene Therapy, 13(6)(6), 598-605. https://doi.org/10.1038/sj.cgt.7700933